Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations

European Journal of Haematology

Volumn 78, Issue 3, 2007, Pages 220-226

  Kunishima, Shinji ^a   Yoshinari, Miyako ^b   Nishio, Hisanori ^c   Ida, Komei ^d   Miura, Takuma ^e   Matsushita, Tadashi ^f   Hamaguchi, Motohiro ^a   Saito, Hidehiko ^g  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e National Hospital Organization Tochigi Medical Center   (Japan)

^f NAGOYA UNIVERSITY   (Japan)

^g Tokai Central Hospital of Japan Mutual Aid Association of Public School Teachers   (Japan)

Author keywords

Epstein syndrome; Macrothrombocytopenia with leukocyte inclusions; MYH9 disorders; Non muscle myosin heavy chain IIA; Ribonucleoprotein complex

Indexed keywords

MYOSIN HEAVY CHAIN; POLYADENYLATED RNA;

ARTICLE; BIOACCUMULATION; BIOTINYLATION; BLEEDING; BLOOD ANALYSIS; BLOOD SMEAR; CASE REPORT; CHILD; EPISTAXIS; FEMALE; GENE; GENE MUTATION; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; INCIDENTAL FINDING; MALE; MICROSCOPY; MOLECULAR PROBE; MUTATIONAL ANALYSIS; MYH9 GENE; NEUTROPHIL; PRIORITY JOURNAL; RNA ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE; THROMBOCYTE TRANSFUSION; THROMBOCYTE VOLUME; THROMBOCYTOPENIA;

ARGININE; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CELL SIZE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCLUSION BODIES; INFANT; MALE; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; NEUTROPHILS; POLY A; THROMBOCYTOSIS;

EID: 33846963188     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00806.x     Document Type: Article

References (23)

1. Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000;26:106-8.
2. Seri M, Cusano R, Gangarossa S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 2000;26:103- 5.
3. Kunishima S, Kojima T, Matsushita T, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 2001;97:1147-9.
4. Heath KE, Campos-Barros A, Toren A, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001;69:1033-45.
5. Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 2001;46:722-9.
6. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003;82:203-15.
7. May R. Leukozyteneinschlusse. Dtsch Arch Klin Med 1909;96:1-6.
8. Hegglin R. Gleichzeitige konstitutionelle Veranderungen an Neutrophilen und Thrombocyten. Helv Med Acta 1945;12:439-40.
9. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998;104:355-60.
10. Bader-Meunier B, Proulle V, Trichet C, Debray D, Gabolde M, Yvart J, Dreyfus M. Misdiagnosis of chronic thrombocytopenia in childhood. J Pediatr Hematol Oncol 2003;25:548-52.
11. Yoshinari M, Kunishima S, Miyabayashi S, Saito H, Tsuchiya S. A unique immunofluorescence method promotes accurate diagnosis in MYH9 disorders: a case report. J Pediatr Hematol Oncol 2004;26:579-83.
12. Dong F, Li S, Pujol-Moix N, Luban NL, Shin SW, Seo JH, Ruiz-Saez A, Demeter J, Langdon S, Kelley MJ. Genotype-phenotype correlation in MYH9-related thrombocytopenia. Br J Haematol 2005;130:620- 7.
13. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo EK, Inoue C, Kamiya T, Saito H. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 2003;83:115-22.
14. Jordan SW, Larsen WE. Ultrastructural studies of the May-Hegglin anomaly. Blood 1965;25:921-32.
15. Jenis MEH, Takeuchi A, Dillon DE, Ruymann MFB, Rivkin S. The May-Hegglin anomaly: ultrastructure of the granulocytic inclusion. Am J Clin Pathol 1971;55:187-96.
16. Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernfield MR, Kushner JH, Ablin AR. Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med 1972;52:299-310.
17. Kunishima S, Kojima T, Tanaka T, Kamiya T, Ozawa K, Nakamura Y, Saito H. Mapping of a gene for May-Hegglin anomaly to chromosome 22q. Hum Genet 1999;105:379-83.
18. Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Brok-Simoni F, Pras E, Rechavi G. Genetic linkage of autosomal-dominant alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13. Am J Hum Genet 1999;65:1711-17.
19. Toren A, Rozenfeld-Granot G, Rocca B, et al. Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13. Blood 2000;96:3447-51.
20. Seri M, Savino M, Bordo D, et al. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet 2002;110:182-6.
21. Lalwani AK, Golstein JA, Kelley MJ, Luxford W, Castelein CM, Mhatre AN. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000;67:1121-8.
22. Otsubo K, Kanegane H, Nomura K, Ogawa J, Miyawaki T, Kunishima S. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly. Pediatr Blood Cancer 2006;47:968-9.
23. Dominguez R, Freyzon Y, Trybus KM, Cohen C. Crystal structure of a vertebrate smooth muscle myosin motor domain and its complex with the essential light chain: visualization of the pre-power stroke state. Cell 1998;94:559-71.